Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies.
Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies. Expert Rev Gastroenterol Hepatol. 2007 Oct; 1(1):101-12.